Cargando…
Non-cell autonomous tumor-growth driving supports sub-clonal heterogeneity
Cancers arise through a process of somatic evolution that can result in substantial sub-clonal heterogeneity within tumors. The mechanisms responsible for the coexistence of distinct sub-clones and the biological consequences of this coexistence remain poorly understood. Here we used a mouse xenogra...
Autores principales: | Marusyk, Andriy, Tabassum, Doris P., Altrock, Philipp M., Almendro, Vanessa, Michor, Franziska, Polyak, Kornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184961/ https://www.ncbi.nlm.nih.gov/pubmed/25079331 http://dx.doi.org/10.1038/nature13556 |
Ejemplares similares
-
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
por: Janiszewska, Michalina, et al.
Publicado: (2019) -
Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growth
por: Edwards, Jack, et al.
Publicado: (2020) -
In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2(+) breast cancer
por: Janiszewska, Michalina, et al.
Publicado: (2015) -
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles
por: Miroshnychenko, Daria, et al.
Publicado: (2023) -
Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)